Learn More
Medchemexpress LLC Liquiritin apioside | 74639-14-8 | 550.51 | 25 MG

Supplier: Medchemexpress LLC 25MGHYN1471
Liquiritin apioside is an orally active inhibitor of the TRPV1 receptor. It selectively inhibits laryngeal chemoreflex (LCR) without significantly affecting mechanoreflex (LMR). It acts by suppressing reactive oxygen species (ROS) and NADPH oxidase, thereby weakening the interaction between ROS and TRPV1. This product is suitable for research concerning respiratory-related diseases.
- Orally active inhibitor of the TRPV1 receptor.
- Selectively inhibits laryngeal chemoreflex (LCR).
- Inhibits LCR by suppressing reactive oxygen species (ROS) and NADPH oxidase.
- Can be used in research of respiratory-related diseases.
- Solid, white to light yellow in appearance.
- Purity of 99.96%.
- For research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.